← All sectors / The AI transformation
175 · Franchised healthcare & retail clinics
Care in the places people already go
Curve position
Binding constraint
Clinician staffing, which limits how many sites can open.
Why this sector sits at Orbit
Franchised healthcare and retail clinics (CVS MinuteClinic, Walgreens Health, urgent care chains) is an established and expanding category with competition on location density, insurance network access, and service scope rather than on technology formation or market access.
Reviewed on a two month cycle. The position moves only when a dated, verifiable change in the binding constraint justifies it.
Heatmap / How this sector's stocks are moving
| Stock | Price | 1 Day | 1 Week | 1 Month | Year to date |
|---|---|---|---|---|---|
| $CVS | $79.96 | −12.53% | −11.11% | −7.49% | +0.76% |
| $USPH | $89.18 | +5.24% | +4.52% | +6.64% | +14.20% |
| $SGRY | $23.16 | +0.13% | −0.34% | +72.71% | +49.90% |
| $THC | $292.25 | +9.58% | +8.85% | +13.07% | +47.07% |
| Sector average | +0.61% | +0.48% | +21.23% | +27.98% |
Prices as of November 5, 2026. The sector's move is the equal-weighted average of these listed companies, a market proxy for context, not recommendations. See it on the full heatmap →
Sentiment / The mood in this sector's stocks
Since 2018, Franchised healthcare & retail clinics has been in Euphoria and steady 11 separate times. After those, its stocks beat their usual three months 6 times (55%), by a median of +0.1 points.
Confidence: low, a split like this is common by chance, so no edge is called.
Getting a primary care appointment has become difficult enough that people go elsewhere, and retail clinics have expanded into that gap. The format works because it is convenient and priced transparently, which is unusual in healthcare.
Historically retail clinics handled minor complaints only and struggled to reach profitability. Broader scope, payer contracts, and chronic care management changed the unit economics.
The structural driver is primary care access failing at the same time that payers want lower cost sites of care. Both point toward retail and franchised formats.
The technology layer spans clinical decision support enabling broader scope for advanced practice clinicians, scheduling and intake, remote physician supervision, point of care diagnostics, and the electronic records connecting a visit back to a primary physician.
Adoption economics depend on visit volume per site and on payer contracts. A site needs consistent throughput, which requires location selection and payer participation to work together.
The beneficiaries include retail clinic operators, point of care diagnostic makers, clinical decision support vendors, staffing platforms supplying clinicians, and the payers reducing emergency utilisation.
The value chain runs from payer through operator to clinician and patient. Clinician supply is the binding constraint on expansion, not real estate or demand.
The overlooked layer includes point of care diagnostics, clinician staffing and credentialing platforms, medical waste and supply services, and the revenue cycle firms handling small claim volumes.
Competitive dynamics have been humbling: several large retailers entered and then substantially retreated after finding the economics harder than expected.
Risks: several high profile retail health ventures have closed, clinician staffing is expensive and scarce, payer reimbursement for these sites is contested, and volume per site is difficult to sustain.
What to watch: site openings versus closures, visits per site, payer contracts for retail sites, and clinician staffing costs.